🇺🇸 FDA
Patent

US 9017661

Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes

granted A61KA61K31/7105A61K38/00

Quick answer

US patent 9017661 (Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes) held by The Board of Regents of the University of Texas System expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/7105, A61K38/00, A61K38/17, A61K45/06